Recombinant plasmids pLP/as and pCP*as were constructed by positioning the Moloney murine leukemia virus (M-MuLV) proviral packaging (at) sequences in reverse orientation under the transcriptional regulation of lymphotropic promoter/regulatory elements from the M-MuLV long terminal repeat or the cytomegalovirus immediate-early region. Linear fragments containing the antisense 'I' and the appropriate transcriptional regulatory sequences from these plasmids were introduced into the mouse germ line by zygote microinjection. The chromosomal integration, germ-line transmission, and lymphocyte-directed expression of the antisense ## RNA were confirmed. Control (nontransgenic) and transgenic mice containing either the pLPqas or the pCPaas sequences were infected with M-MuLV on the day of birth and assayed for signs ofleukemia between 12 and 14 weeks of age with standard assay procedures. While 31% (11 of 36) of the control, nontransgenic, mice developed leukemia, none of the antisense 4i transgenic mice developed any symptoms of leukemia. The pCPabas sequences were also introduced into mouse NIH 3T3 cells and stably transformed cell lines were isolated. When infected with M-MuLV these cells were shown to produce virus devoid of packaged viral RNA.
Retroviruses require only a very limited number of genes and genetic regulatory sequences to complete their cycle of infection in host cells or organisms (1) (2) (3) (4) . This remarkable molecular efficiency partially explains why retroviruses such as human immunodeficiency virus (HIV) act so effectively as pathogens, but may also suggest targets for molecular attenuation of retroviral replication in host organisms. Among the most stringent requirements for retroviral replication are cis-acting viral genomic sequences necessary for the specific encapsidation of genomic viral RNA molecules into virus particles (4) (5) (6) (7) (8) (9) (10) . These packaging (4i) sequences have been identified and used extensively as the basis of retroviral vectors designed for gene transfer (10) (11) (12) (13) . Results from these combined studies suggest that interference with the specific interactions between these 4i sequences and virion capsid proteins will block the retroviral replication cycle.
The use of antisense RNA to inhibit RNA function within cells and whole organism has provided a valuable molecular method (14) (15) (16) . Antisense RNA can bind in a highly specific manner to complementary sequences, blocking the ability of the bound RNA to be processed or translated or, possibly, even to interact with sequence-specific binding proteins (17) (18) (19) (20) . To test the efficacy of antisense RNA complementary to the sequences of a murine retrovirus in blocking retroviral replication, transgenic mice expressing RNA sequences complementary to the q, sequences of Moloney murine leukemia virus (M-MuLV) were produced and then challenged with this virus.
MATERIALS AND METHODS
Plasmids. Recombinant plasmids pLPqias and pCP/as were constructed as shown in Fig. 1 (36 ,ug) and pSV2neo (0.36 ,ug) (ATCC 33694), using a modified DEAE-dextran/dimethyl sulfoxide shock procedure (24) .
Transgenic Mouse Production. The procedure for the production of transgenic mice by direct microinjection of DNA into the male pronucleus of fertilized mouse eggs has been described (25) . DNA extraction from mouse tails and slot blot hybridization analysis of the progeny resulting from these microinjected eggs were performed as described (26) .
DNA and RNA Analysis and Enzyme Assays. The integrity of DNA sequences in transgenic mice was analyzed by the method of Southern (27) . RNA was prepared from lymphocytes by a single-step isolation method (28) using a FicollPaque gradient (29) . RNA was then subjected to electrophoresis at 70 V for 4.5 hr in a 1.2% agarose/formaldehyde gel and transferred onto nitrocellulose paper for hybridization and radioautography as described (23) . Reverse transcriptase assays were performed as described (30) . To distinguish the antisense RNA products, a strand-specific RNA probe was used for Northern hybridization analysis of lymphocyte RNA. This probe was synthesized from a pSP65 vector containing the 540-bp Sma I sequence in the sense orientation at the unique Sma I site of plasmid pSP65 by using SP6 RNA polymerase and [a-32P]GTP (Riboprobe system, Promega).
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. fertilized mouse eggs (200-500 copies per egg). These eggs were subsequently transplanted into the oviducts of pseudopregnant foster recipient mice. When the resulting offspring were about 1 month old, a segment ofthe tail of each animal was removed and DNA was prepared from it. Transgenic mice were detected by DNA slot blot and Southern transfer hybridizations (Fig. 2) . Two lines of transgenic mice (Lqas and Cqas) were analyzed and used in this study. Lqras transgenic mice are derived from a single founder mouse resulting from the microinjection of the 2.2-kb HindIII fragment from pLPqias, and Cfas transgenic mice are derived from a single founder from the microinjection of the 2.3-kb EcoRI-Cla I fragment from pCPifas.
Tail DNA (10 ,ug) from the Lqras founder and his offspring was digested with Sac I and EcoRI restriction endonucleases and Cras founder and offspring DNA was digested with Kpn I and then subjected to electrophoresis. A nick-translated DNA probe (5-10 x 108 cpm/pug) was prepared from pBR322 for analysis of Lqias DNA (because of the presence of pBR322 sequences in LI/as construction this provides a good probe that does not crossreact with endogenous retroviral sequences), and a 1.3-kb Sac I-Eco RI fragment from pCPI/as was used as the probe for Cl/as DNA. From the Southern blots in Fig. 2 it is clear that both LI/as and Co-as mice contain complete transcription units for the production of the 540-base antisense sequences integrated into their chromosomal components. For LI/as DNA, the 1470-bp hybridizing Sac I-EcoRI fragment shown by each Lias mouse confirms the presence of the appropriate sequences, and Co/as mouse DNA from each animal shows the characteristic 400-bp hybridizing Kpn I fragment (Fig. 2) . (Fig. 4) .
Reverse transcriptase activity in the supernatant from the stable cell line expressing antisense f RNA after infection with M-MuLV was measured and compared with that in the supernatant from normal mouse NIH 3T3 cells also infected with M-MuLV (30) . Substantial reverse transcriptase activity was observed (Table 1 ) even though this same supernatant was shown to be devoid of viral genomic RNA (Fig. 4) . were mated to nontransgenic (C57B6/SJL) females. Within several hours after birth each offspring from these matings was injected i.p. with 0.1 ml containing 105 infectious M-MuLV virions. Four weeks after birth a DNA sample from the tail of each mouse pup was analyzed by slot blot hybridization and each mouse ear was notched to code transgenic and nontransgenic offspring. At 12-14 weeks of age transgenic and control mice were sacrificed and assayed for the presence of leukemia symptoms. Mice were judged to be leukemic if three criteria were met: spleen weight of >0.5 g, a hematocrit value of c35%, and typical leukemia morphology in Giemsa-stained lymphocytes (35) . Table 2 shows these data for each transgenic and control mouse. Whereas 31% (11/36) of the control mice showed the symptoms of leukemia, none of the Lfas or Cfas mice were judged to be (Fig. 4) . In spite of the lack of viral RNA in the cell supernatant, significant reverse transcriptase activity was measured (30) ( Table 1 ), suggesting that the cells expressing antisense 4i RNA were producing empty viral particles because of antisense blockage of the packaging process. While the cell culture model suggests a mechanism for the inhibition of M-MuLV-induced leukemia in antisense /,-expressing transgenic mice, further studies of the molecular interactions of the M-MuLV antisense q1 sequences in these mice will be required to confirm the mode of inhibition.
The data presented here call attention to the possibility of using antisense RNA or DNA molecules complementary to retroviral packaging sequences as potential therapeutic agents in the treatment of diseases in which the causative agent is a retrovirus.
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